Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT

A legfontosabb adatok

Hol
Ann Arbor, Chapel Hill, Hartford, Iowa City, Orlando, Palo Alto, Philadelphia, Rochester és Seattle (Egyesült Államok)Mind a 9 helyszín megnézése

Helyszínek itt: Egyesült Államok

  • University of MichiganAnn Arbor, Egyesült ÁllamokNo longer taking part
  • University of North CarolinaChapel Hill, Egyesült ÁllamokNo longer taking part
  • University of Connecticut/Connecticut Children's Medical CenterHartford, Egyesült ÁllamokNo longer taking part
  • University of IowaIowa City, Egyesült ÁllamokNo longer taking part
  • Nemours Children's ClinicOrlando, Egyesült ÁllamokNo longer taking part
  • Stanford UniversityPalo Alto, Egyesült ÁllamokNo longer taking part
  • Children's Hospital of PhiladelphiaPhiladelphia, Egyesült ÁllamokNo longer taking part
  • University of RochesterRochester, Egyesült ÁllamokNo longer taking part
  • Seattle Children's HospitalSeattle, Egyesült ÁllamokNo longer taking part

A vizsgálat adatai

Ki végzi
University of Iowa
Azonosító
NCT01203085
A regiszteradat frissítve
2026. október 27.
Eredeti leírás
The primary goal of this project is to develop and test a Charcot Marie Tooth disease (CMT) Pediatric Scale for use in evaluation in natural history CMT study.A teljes eredeti leírásKevesebb

Development and Validation of CMT Pediatric Scale for Children With Charcot Marie Tooth

The primary goal of this project is to develop and test a Charcot Marie Tooth disease (CMT) Pediatric Scale for use in evaluation in natural history CMT study.

Bevonási feltételek: All patients MUST be seen in person at one of the participating centers for enrollment in this study; Children (< 21 years of age); Known or probable inherited neuropathies classified as CMT1, CMT2, or CMT4.

Kizáró feltételek: Known diagnoses of acquired neuropathy including toxic (e. g. medication related neuropathies); metabolic (e.g. diabetic), immune mediated or inflammatory [acute inflammatory demyelinating polyradiculoneuropathy (AIDP) or chronic inflammatory demyelinating polyneuropathy (CIDP)] polyneuropathies; neuropathy related to leukodystrophy, congenital muscular dystrophy; and patients with severe general medical conditions; Entirely normal conduction velocities of upper and lower limbs as this suggests that the subject may not have a neuropathy.

ClinicalTrials.gov NCT01203085